Literature DB >> 26070777

Editor's Spotlight/Take 5: A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.

Seth S Leopold1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26070777      PMCID： PMC4523547          DOI： 10.1007/s11999-015-4401-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  α-Defensin as a predictor of periprosthetic shoulder infection.

Authors:  Salvatore J Frangiamore; Anas Saleh; Matthew J Grosso; Mario Farias Kovac; Carlos A Higuera; Joseph P Iannotti; Eric T Ricchetti
Journal:  J Shoulder Elbow Surg       Date:  2015-02-08       Impact factor: 3.019

2.  The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty.

Authors:  Joshua Bingham; Henry Clarke; Mark Spangehl; Adam Schwartz; Christopher Beauchamp; Brynn Goldberg
Journal:  Clin Orthop Relat Res       Date:  2014-09-26       Impact factor: 4.176

Review 3.  MRSA prevention strategies and current guidelines.

Authors:  F M Byrne; M H Wilcox
Journal:  Injury       Date:  2011-12       Impact factor: 2.586

4.  Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors.

Authors:  Tessie B McNeely; Najaf A Shah; Arthur Fridman; Amita Joshi; Jonathan S Hartzel; Ravi S Keshari; Florea Lupu; Mark J DiNubile
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Osteomyelitis.

Authors:  Daniel P Lew; Francis A Waldvogel
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

6.  Diagnosing periprosthetic joint infection: has the era of the biomarker arrived?

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Alexander Cameron; Kevin Schiller; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.